LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR) a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that Steven A. Kriegsman, President and CEO, and Tod Woolf, Ph.D., President and CEO of RXi Pharmaceuticals Corporation, CytRx’s majority-owned RNAi subsidiary, will present at the UBS Global Life Sciences Conference on Monday, September 24 at 10:30 a.m. Eastern time (7:30 a.m. Pacific time). This conference will be held at the Grand Hyatt New York in New York City.
